Background illustration for clinical trials search

Paid Clinical Trials New Hampshire

Discover 273 paid clinical trials in New Hampshire. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Boston MA, Lebanon NH, Quebec, Lake Success NY,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06203210

Phase3, Recruiting

Nutrition to Support Postoperative Recovery

for
Postoperative Care, Postoperative Complications, Cognition,
Location: Lebanon NH
Sponsor: Dartmouth-Hitchcock Medical Center

Sex: All

Age: 70+

Code: NCT07109505

Recruiting

Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients

for
Breast Cancer, Adjuvant Treatment, Early Stage Breast Cancer
Location: Lebanon NH
Sponsor: Dartmouth-Hitchcock Medical Center

Sex: All

Age: 18+

Code: NCT07071038

Phase2, Recruiting

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Brunswick ME, Portland ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06672146

Phase2, Recruiting

Neural Mechanisms of Interpersonal Expectations on Negative Affect

for
Negative Affectivity, Non-invasive Brain Stimulation,
Location: Hanover NH
Sponsor: Trustees of Dartmouth College

Sex: All

Age: 18 - 55

Code: NCT06980090

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically

for
Non-Melanoma Skin Cancer (NMSC), Benign Skin Growth
Location: Lebanon NH
Sponsor: Dartmouth-Hitchcock Medical Center

Sex: All

Age: 18+

Code: NCT07201376

Recruiting

HCQ in Resectable Localized Prostate Cancer

for
Resectable Localized Prostate Cancer
Location: Lebanon NH
Sponsor: Lionel.D.Lewis, MD

Sex: Male

Age: 18+

Code: NCT06408298

Early_phase1, Recruiting

A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

for
Hidradenitis Suppurativa
Location: Greenland NH, Barrie, Tampa FL, Fort Gratiot MI,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT07244263

Phase2, Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Boston MA, Lebanon NH, Commack NY, Uniondale NY,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07097142

Phase3, Recruiting

Chronic Radiation Cystitis and Effect of Hyperbaric Oxygen Therapy on Patient Reported Outcomes and Urine Inflammatory Biomarkers

for
Radiation Cystitis, Urinary Tract Infection (Diagnosis)
Location: Lebanon NH
Sponsor: Rachel A. Moses

Sex: All

Age: 18+

Code: NCT07368647

Recruiting

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

for
Advanced Hepatocellular Carcinoma,
Location: Boston MA, Waterford CT, Guilford CT, Glastonbury CT,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07166406

Phase3, Recruiting

Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer

for
Ovarian Cancer
Location: Manchester NH, Lebanon NH
Sponsor: Tyler J Curiel

Sex: Female

Age: 18+

Code: NCT06815497

Phase2, Recruiting

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Brewer ME, Lebanon NH, Stony Brook NY, Long Branch NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07195734

Phase2, Recruiting

A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Lebanon NH, Stamford CT, Miami FL, Tampa FL, El Paso TX
Sponsor: Kedrion S.p.A.

Sex: All

Age: 18+

Code: NCT06752356

Phase3, Recruiting

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

for
Glioblastoma
Location: Providence RI, Lebanon NH, Valhalla NY, Neptune City NJ,
Sponsor: GT Medical Technologies, Inc.

Sex: All

Age: 18+

Code: NCT07195591

Phase3, Recruiting

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Scarborough ME, Burlington MA, New Haven CT, Lebanon NH,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07085767

Phase3, Recruiting

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Scarborough ME, Providence RI, Farmington CT,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213804

Phase3, Recruiting

Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer

for
Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer,
Location: Lebanon NH, Atlanta GA, Milwaukee WI, Honolulu HI
Sponsor: OncoTherapy Science, Inc.

Sex: All

Age: 18+

Code: NCT02926690

Phase1, Recruiting

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

for
Locally Advanced Urothelial Carcinoma,
Location: Worcester MA, Lebanon NH, Stony Brook NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06524544

Phase3, Recruiting

I-DECIDE After Bronchiolitis Hospitalization

for
Bronchiolitis Acute
Location: Bangor ME, Boston MA, Providence RI, Manchester NH,
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 2

Code: NCT07243652

Recruiting

Popular cities in New Hampshire

New Hampshire stands out as a key location for clinical trials, thanks to its strong healthcare network and renowned medical research institutions. Dartmouth-Hitchcock Medical Center and the Geisel School of Medicine at Dartmouth are at the forefront of innovative studies, particularly in areas such as cancer, cardiovascular diseases, and neurological conditions.

With access to cutting-edge medical technology and expertise, these institutions contribute significantly to groundbreaking advancements in medical research.

Why choose New Hampshire for clinical trials?

New Hampshire presents unique opportunities for individuals participating in clinical trials. The state's blend of urban and rural populations provides a diverse pool of participants, enhancing the accuracy and relevance of research outcomes. New Hampshire is also known for its innovative approach to healthcare, with a strong emphasis on medical advancements and collaboration among its leading research institutions.

By choosing to participate in a clinical trial in New Hampshire, individuals contribute to critical medical research while benefiting from a well-established and supportive clinical trial infrastructure. This not only ensures high-quality care but also plays a crucial role in shaping the future of medical treatments and healthcare advancements.

Common conditions studied in New Hampshire

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in New Hampshire